Table 1.
Variable | Total (N = 1738) | Hoehn and Yahr Stage | Heterogeneity (P Value) | Trend (P Value) | ||
---|---|---|---|---|---|---|
1 (N = 855) | 2 (N = 783) | 3 + (N = 100) | ||||
Age (y) | 67.6 (9.3) | 66.1 (9.2) | 68.7 (9.0) | 71.8 (9.1) | <0.001a | <0.001a |
Age at diagnosis (y) | 66.3 (9.2) | 64.9 (9.2) | 67.3 (9.0) | 70.3 (9.1) | <0.001a | <0.001a |
Duration (y) | 1.3 (0.9) | 1.2 (0.9) | 1.4 (0.9) | 1.4 (1.0) | <0.001b | <0.001b |
Male sex | 1132 (65.1%) | 539 (63.0%) | 540 (69.0%) | 53 (53.0%) | 0.001c | 0.88c |
Drug naïve | 168 (9.7%) | 108 (12.6%) | 56 (7.2%) | 4 (4.1%) | 0.007 d | 0.001d |
LEDD (mg) | 294 (205) | 264 (208) | 320 (202) | 353 (158) | <0.001d | <0.001d |
MDS UPDRS 3 | 22.5 (12.1) | 16.8 (8.8) | 26.4 (11.3) | 40.1 (13.7) | <0.001d | <0.001d |
Motor Subtype | ||||||
Tremor dominant | 763 (46.9%) | 414 (51.7%) | 339 (46.2%) | 10 (10.8%) | ||
PIGD | 652 (40.1%) | 273 (34.1%) | 306 (41.7%) | 73 (78.5%) | <0.001d | <0.001d |
Indeterminate | 212 (13.0%) | 114 (14.2%) | 88 (12.0%) | 10 (10.8%) | 0.018d | 0.45d |
SCOPA‐AUT total | 11.7 (7.0) | 10.7 (6.2) | 12.7 (7.6) | 13.5 (6.9) | <0.001d | <0.001d |
Eight cases with missing H&Y status are not shown; data are presented as mean and standard deviation or percentage.
LEDD, l‐dopa equivalent daily dose; MDS UPDRS 3, Movement Disorder Society Unified Parkinson's disease rating scale Part 3; PIGD, postural instability and gait difficulty; SCOPA‐AUT, scales for outcomes in Parkinson's disease—autonomic symptoms.
Adjusted for sex and disease duration.
Adjusted for sex and age.
Adjusted for age and disease duration.
Adjusted for sex, age, and disease duration.